Photosensitizer, Pharmaceutical Composition Compounding It, and Its Use in Photodynamic Therapy

Patent number:

ES3014477

Castilla La Mancha.svg
No items found.

The present invention describes a photosensitizer for photodynamic therapy comprising polymer clusters based on terpenes or derivatives thereof, which can fully function as a traditional chromophoric system. The present invention also relates to a pharmaceutical composition comprising such a photosensitizer and its use in photodynamic therapy.

Countries:
Spain
Regions:
Castile-La Mancha
Centers:
UNIVERSIDAD DE CASTILLA LA MANCHA
Other entities:
INSTITUT QUÍMIC DE SARRIÀ CETS FUNDACIÓ PRIVADA - UNIVERSITAT RAMON LLULL FUNDACIÓ
Sectors:
Health
Subsectors:
Biotechnology
TRL Level:
TRL 4 – technology validated in lab
BRL Level:
BRL1: Hypothesizing on possible business concept
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

The use of non-conjugated chromophoric systems, whose emission and generation of reactive oxygen species increase with aggregation, offers a solution to the problems described for conventional photosensitizers. Systems with these characteristics are based on the intrinsic emission of non-traditional chromophores due to molecular cluster aggregation (CTE). The use of this new type of photosensitizer with this emission mechanism will be a revolutionary alternative to existing ones, since many materials exhibiting the CTE phenomenon are approved by regulatory agencies such as the FDA/EMA for other uses (e.g., excipients), making clinical translation much faster.

Comments

Other related patents

Health

METHOD FOR SELECTING, MANIPULATING AND ISOLATING CIRCULATING TUMOR CELLS IN BODY FLUIDS BY LASER-ASSISTED TRANSFER

Countries
Spain
Know more
Health

Use of PI3K inhibitors for the treatment of obesity, steatosis and ageing

Countries
Spain
Know more
Health

AN AZAPYRIDINOPHAN COMPOUND AS AN ANTIFUNGAL

Countries
Spain
Know more
Get back to patents directory